EMD Serono names VP, medical affairs
This article was originally published in Scrip
Executive Summary
Rockland, Massachusetts-based EMD Serono, the US biopharmaceuticals subsidiary of Germany's Merck KGaA, has appointed Dr Frederick E Munschauer vice-president of medical affairs, neurology and immunology. In this capacity, Dr Munschauer will lead the medical affairs activities for clinical, commercial and business development projects and collaborations for Rebif (interferon beta-1a) as well as the company’s immunology and neurology pipeline. He joins EMD Serono from Biogen, where he was chief medical advisor.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.